Zobrazeno 1 - 10
of 328
pro vyhledávání: '"E. Eichhorn"'
Autor:
Laura V. Klotz, Julia Zimmermann, Karolina Müller, Julia Kovács, Mohamed Hassan, Michael Koller, Severin Schmid, Gunnar Huppertz, Till Markowiak, Bernward Passlick, Hans-Stefan Hofmann, Hauke Winter, Rudolf A. Hatz, Martin E. Eichhorn, Michael Ried
Publikováno v:
Cancers, Vol 16, Iss 8, p 1587 (2024)
Cytoreductive surgery (CRS) combined with hyperthermic intrathoracic chemoperfusion (HITOC) is a promising treatment strategy for pleural mesothelioma (PM). The aim of this study was to evaluate the impacts of this multimodal approach in combination
Externí odkaz:
https://doaj.org/article/79804bda18b641bc98df31e418e81f4b
Autor:
Mohamed Hassan, Julia Zimmermann, Severin Schmid, Bernward Passlick, Julia Kovács, Rudolf Hatz, Hauke Winter, Laura V. Klotz, Martin E. Eichhorn, Till Markowiak, Karolina Müller, Gunnar Huppertz, Michael Koller, Hans-Stefan Hofmann, Michael Ried
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe role of cytoreductive surgery combined with hyperthermic intrathoracic chemotherapy (CRS+HITOC) for patients with secondary pleural metastases has scarcely been investigated.Patients and MethodsWe conducted a retrospective, multicentre
Externí odkaz:
https://doaj.org/article/1a7a8ac6698142aa8ff55e5f77c952ff
Autor:
Miriam Blasi, Martin E. Eichhorn, Petros Christopoulos, Hauke Winter, Claus Peter Heußel, Felix J. Herth, Rami El Shafie, Katharina Kriegsmann, Mark Kriegsmann, Albrecht Stenzinger, Helge Bischoff, Michael Thomas, Jonas Kuon
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Data are currently insufficient to support the use of adjuvant chemotherapy (ACT) after surgical resection for stage II or III non-small cell lung cancer (NSCLC) in patients aged ≥ 75 years. In this study we evaluated efficacy a
Externí odkaz:
https://doaj.org/article/1b53ff915d164d97a52c735bb73255f9
Autor:
Florian Eichhorn, Laura V. Klotz, Helge Bischoff, Michael Thomas, Felix Lasitschka, Hauke Winter, Hans Hoffmann, Martin E. Eichhorn
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Immunotherapies targeting the PD1/PD-L1 pathway have had a large impact on the treatment of advanced NSCLC. Concerning multimodality tumor therapy, only few trials until today have been performed investigating neoadjuvant treatmen
Externí odkaz:
https://doaj.org/article/50b5756cf3ef479797e0cc786108831c
Autor:
Laura V. Klotz, Yves Courty, Michael Lindner, Agnès Petit‐Courty, Anja Stowasser, Ina Koch, Martin E. Eichhorn, Ioannis Lilis, Alicia Morresi‐Hauf, Kristina A. M. Arendt, Mario Pepe, Ioanna Giopanou, Giannoula Ntaliarda, Sabine J. Behrend, Maria Oplopoiou, Valérie Gissot, Serge Guyetant, Sylvain Marchand‐Adam, Jürgen Behr, Jan‐Christian Kaiser, Rudolf A. Hatz, Anne‐Sophie Lamort, Georgios T. Stathopoulos
Publikováno v:
Cancer Medicine, Vol 8, Iss 4, Pp 1486-1499 (2019)
Abstract A comprehensive characterization of lung adenocarcinoma (LADC) clinical features is currently missing. We prospectively evaluated Caucasian patients with early‐stage LADC. Patients with LADC diagnosed between 2011 and 2015 were prospective
Externí odkaz:
https://doaj.org/article/a89f35a0d3da42bf97712614c7c2bd44
Autor:
Michael Ried, Julia Kovács, Till Markowiak, Karolina Müller, Gunnar Huppertz, Michael Koller, Hauke Winter, Laura V. Klotz, Rudolf Hatz, Julia Zimmermann, Bernward Passlick, Severin Schmid, Mohamed Hassan, Martin E. Eichhorn, Hans-Stefan Hofmann
Publikováno v:
Cancers, Vol 13, Iss 18, p 4580 (2021)
In the context of quality assurance, the objectives were to describe the surgical treatment and postoperative morbidity (particularly renal insufficiency). A retrospective, multicentre study of patients who underwent cytoreductive surgery (CRS) with
Externí odkaz:
https://doaj.org/article/42c178b3bc05423a850037f11b690834
Autor:
Philip Baum, Samantha Taber, Stella Erdmann, Thomas Muley, Mark Kriegsmann, Petros Christopoulos, Michael Thomas, Hauke Winter, Joachim Pfannschmidt, Martin E. Eichhorn
Publikováno v:
Cancers, Vol 13, Iss 8, p 1812 (2021)
The current pT3N0 category represents a heterogeneous subgroup involving tumor size, separate tumor nodes in one lobe, and locoregional growth pattern. We aim to validate outcomes according to the eighth edition of the TNM staging classification. A t
Externí odkaz:
https://doaj.org/article/2225509197b847fb99dbb25b3fecac82
Autor:
Florian Eichhorn, Mark Kriegsmann, Laura V. Klotz, Katharina Kriegsmann, Thomas Muley, Christiane Zgorzelski, Petros Christopoulos, Hauke Winter, Martin E. Eichhorn
Publikováno v:
Cancers, Vol 13, Iss 9, p 2046 (2021)
The programmed death-ligand 1 (PD-L1) plays a crucial role in immunomodulatory treatment concepts for end-stage non-small cell lung cancer (NSCLC). To date, its prognostic significance in patients with curative surgical treatment but regional nodal m
Externí odkaz:
https://doaj.org/article/d11972d735f94427ab3fd5a87b17691a
Autor:
Michael Ried, Mohamed Hassan, Bernward Passlick, Severin Schmid, Till Markowiak, Karolina Müller, Gunnar Huppertz, Michael Koller, Hauke Winter, Laura V Klotz, Rudolf Hatz, Julia Kovács, Julia Zimmermann, Hans-Stefan Hofmann, Martin E Eichhorn
Publikováno v:
Interdisciplinary CardioVascular and Thoracic Surgery.
Objectives Cytoreductive surgery and hyperthermic intrathoracic chemotherapy (HITOC) is effective on survival for patients with pleural metastatic thymic tumours. Methods Multicentre, retrospective analysis of patients with stage IVa thymic tumours t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.